How Datavault AI Inc. is turning U.S. critical minerals into digital assets through American Strategic Minerals Inc. deal (NASDAQ: DVLT)
Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 3 minute read Pharma Industry News Pfizer’s IBRANCE fails to meet primary endpoint in PENELOPE-B breast cancer trial The latest results from Pfizer’s Phase 3 PENELOPE-B clinical trial have cast a shadow over the potential of… bypharmanewsdailyOctober 11, 2020
